Chromadex Corp
Save
421.64M
Market cap
276x
Current P/E
42.37x
Forward P/E
About
Health care
Sector
Biotechnology
Industry
ChromaDex Corporation operates as a bioscience company focusing on healthy aging. The company operates through three segments: Consumer products; Ingredients; and Analytical Reference Standards and Services. It researches on nicotinamide adenine dinucleotide (NAD+); provides finished dietary supplement products that contain its proprietary ingredients directly to consumers, as well as to distributors; and develops and commercializes proprietary-based ingredient technologies and supplies these ingredients as raw materials to the manufacturers of consumer products.
Similar securities
Based on sector and market capitalization
Report issue